ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
vilkĀbele plus (2016.) kapsula
biosola, sia (uab) - kapsula
vilkĀbeles uzlĒjums (paziņots 2009.) šķidrums
es - šķidrums
grazax 75000 sq-t liofilizāts lietošanai zem mēles
alk-abello a/s, denmark - pļcavas timotiņa ziedputekšņu ekstrakts - liofilizāts lietošanai zem mēles - 75000 sq-t
mabelle preconception (2024.) kapsula
kapsula
mabelle pregnancy (2024.) kapsula
kapsula
mabelle breastfeeding (2024.) kapsula
kapsula
vilkĀbele plus (paziņots 2010.) kapsula
minskinterkaps - kapsula
vilkĀbele max (2022.) kapsula
kapsula
vilkābeles komplekss (2022.) kapsula, -
kapsula, -